Brigitte A. Van Den Broek
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis.
Journal: Frontiers in immunology
Published: June 15, 2021
Hurdles in treating Hurler disease: potential routes to achieve a "real" cure.
Journal: Blood advances
Published: February 20, 2020
Hearing loss in patients with mucopolysaccharidoses-1 and -6 after hematopoietic cell transplantation: A longitudinal analysis.
Journal: Journal of inherited metabolic disease
Published: February 10, 2020
Quantifying lymphocyte vacuolization serves as a measure of CLN3 disease severity.
Journal: JIMD reports
Published: August 08, 2019
Longitudinal Analysis of Ocular Disease in Children with Mucopolysaccharidosis I after Hematopoietic Cell Transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: May 14, 2019
Salivary α-Iduronidase Activity as a Potential New Biomarker for the Diagnosis and Monitoring the Effect of Therapy in Mucopolysaccharidosis Type I.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: April 04, 2018
QuantiFERON-plus does not discriminate between active and latent tuberculosis.
Journal: Infectious diseases (London, England)
Published: January 17, 2018
A Case of Unexpected Adult-Onset Neurologic Decline in CLN3-Associated Retinal Degeneration.
Journal: JAMA ophthalmology
Published: October 20, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026